Matches in Wikidata for { <http://www.wikidata.org/entity/Q46576489> ?p ?o ?g. }
- Q46576489 description "2013 nî lūn-bûn" @default.
- Q46576489 description "2013 թվականի նոյեմբերի 7-ին հրատարակված գիտական հոդված" @default.
- Q46576489 description "2013年の論文" @default.
- Q46576489 description "2013年学术文章" @default.
- Q46576489 description "2013年学术文章" @default.
- Q46576489 description "2013年学术文章" @default.
- Q46576489 description "2013年学术文章" @default.
- Q46576489 description "2013年学术文章" @default.
- Q46576489 description "2013年学术文章" @default.
- Q46576489 description "2013年學術文章" @default.
- Q46576489 description "2013年學術文章" @default.
- Q46576489 description "2013年學術文章" @default.
- Q46576489 description "2013年學術文章" @default.
- Q46576489 description "2013年學術文章" @default.
- Q46576489 description "2013년 논문" @default.
- Q46576489 description "article científic" @default.
- Q46576489 description "article scientific" @default.
- Q46576489 description "article scientifique" @default.
- Q46576489 description "articol științific" @default.
- Q46576489 description "articolo scientifico" @default.
- Q46576489 description "artigo científico" @default.
- Q46576489 description "artigo científico" @default.
- Q46576489 description "artigo científico" @default.
- Q46576489 description "artikel ilmiah" @default.
- Q46576489 description "artikull shkencor" @default.
- Q46576489 description "artikulong pang-agham" @default.
- Q46576489 description "artykuł naukowy" @default.
- Q46576489 description "artículo científico publicado en 2013" @default.
- Q46576489 description "artículu científicu" @default.
- Q46576489 description "bilimsel makale" @default.
- Q46576489 description "bài báo khoa học" @default.
- Q46576489 description "naučni članak" @default.
- Q46576489 description "scienca artikolo" @default.
- Q46576489 description "scientific article published on 7 November 2013" @default.
- Q46576489 description "scientific article published on 7 November 2013" @default.
- Q46576489 description "scientific article published on 7 November 2013" @default.
- Q46576489 description "teaduslik artikkel" @default.
- Q46576489 description "tieteellinen artikkeli" @default.
- Q46576489 description "tudományos cikk" @default.
- Q46576489 description "vedecký článok" @default.
- Q46576489 description "vetenskaplig artikel" @default.
- Q46576489 description "videnskabelig artikel" @default.
- Q46576489 description "vitenskapelig artikkel" @default.
- Q46576489 description "vitskapeleg artikkel" @default.
- Q46576489 description "vědecký článek" @default.
- Q46576489 description "wetenschappelijk artikel" @default.
- Q46576489 description "wissenschaftlicher Artikel" @default.
- Q46576489 description "επιστημονικό άρθρο" @default.
- Q46576489 description "мақолаи илмӣ" @default.
- Q46576489 description "наукова стаття, опублікована в листопаді 2013" @default.
- Q46576489 description "научна статия" @default.
- Q46576489 description "научная статья" @default.
- Q46576489 description "научни чланак" @default.
- Q46576489 description "научни чланак" @default.
- Q46576489 description "מאמר מדעי" @default.
- Q46576489 description "مقالة علمية نشرت في 7 نوفمبر 2013" @default.
- Q46576489 description "৭ নভেম্বর ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q46576489 description "บทความทางวิทยาศาสตร์" @default.
- Q46576489 description "სამეცნიერო სტატია" @default.
- Q46576489 name "Combined treatment using adoptive cell therapy, extended pharmacokinetic IL-2, and tumor-specific antibodies leads to cures of established B16F10 tumors and extended in vivo T cell survival." @default.
- Q46576489 name "Combined treatment using adoptive cell therapy, extended pharmacokinetic IL-2, and tumor-specific antibodies leads to cures of established B16F10 tumors and extended in vivo T cell survival." @default.
- Q46576489 type Item @default.
- Q46576489 label "Combined treatment using adoptive cell therapy, extended pharmacokinetic IL-2, and tumor-specific antibodies leads to cures of established B16F10 tumors and extended in vivo T cell survival." @default.
- Q46576489 label "Combined treatment using adoptive cell therapy, extended pharmacokinetic IL-2, and tumor-specific antibodies leads to cures of established B16F10 tumors and extended in vivo T cell survival." @default.
- Q46576489 prefLabel "Combined treatment using adoptive cell therapy, extended pharmacokinetic IL-2, and tumor-specific antibodies leads to cures of established B16F10 tumors and extended in vivo T cell survival." @default.
- Q46576489 prefLabel "Combined treatment using adoptive cell therapy, extended pharmacokinetic IL-2, and tumor-specific antibodies leads to cures of established B16F10 tumors and extended in vivo T cell survival." @default.
- Q46576489 P1433 Q46576489-5996FBD6-5A84-4504-8C27-136311720B91 @default.
- Q46576489 P1476 Q46576489-57727BF9-1E12-492B-9EB0-35DA0FBF27BA @default.
- Q46576489 P2093 Q46576489-C0019317-DC66-475B-AAF3-17C2AB0026D9 @default.
- Q46576489 P275 Q46576489-791120eb-eb8a-414a-a062-f2ab5ad41245 @default.
- Q46576489 P2888 Q46576489-9D7DE65A-0479-4370-A0D6-73CAD7ACB6C5 @default.
- Q46576489 P304 Q46576489-344D90DE-D531-4256-A711-B755D268F7B6 @default.
- Q46576489 P31 Q46576489-2074AC8A-C8CB-4F36-9208-6BA5450EB9FB @default.
- Q46576489 P356 Q46576489-994478C6-84BF-4952-8581-651B381A7372 @default.
- Q46576489 P433 Q46576489-17F8F5ED-6445-4741-94F8-D5B6F2AF9B22 @default.
- Q46576489 P478 Q46576489-AE7CBE1E-5861-43AF-9DCA-8FEF39637155 @default.
- Q46576489 P50 Q46576489-84FC9BF2-7A97-4BCF-A3D4-B7EA3B706CB5 @default.
- Q46576489 P577 Q46576489-DB882078-5F27-43D7-A379-B218A1962E85 @default.
- Q46576489 P6179 Q46576489-8CF88579-A24A-4094-8B55-537CBF0D9B17 @default.
- Q46576489 P6216 Q46576489-db7f3f83-ea39-4da6-83c5-3b34003edd07 @default.
- Q46576489 P8608 Q46576489-6FA9FC6F-C32F-46ED-85C1-8856FC62EDB0 @default.
- Q46576489 P921 Q46576489-18A4433F-11AD-4A74-B848-C2F50260A309 @default.
- Q46576489 P932 Q46576489-06402298-8330-4AFD-AE4B-DCA884A4F18E @default.
- Q46576489 P356 2051-1426-1-S1-P26 @default.
- Q46576489 P1433 Q27725163 @default.
- Q46576489 P1476 "Combined treatment using adoptive cell therapy, extended pharmacokinetic IL-2, and tumor-specific antibodies leads to cures of established B16F10 tumors and extended in vivo T cell survival" @default.
- Q46576489 P2093 "K Dane Wittrup" @default.
- Q46576489 P275 Q19125117 @default.
- Q46576489 P2888 2051-1426-1-s1-p26 @default.
- Q46576489 P304 "P26-P26" @default.
- Q46576489 P31 Q13442814 @default.
- Q46576489 P356 "10.1186/2051-1426-1-S1-P26" @default.
- Q46576489 P433 "Suppl 1" @default.
- Q46576489 P478 "1" @default.
- Q46576489 P50 Q84786771 @default.
- Q46576489 P577 "2013-11-07T00:00:00Z" @default.
- Q46576489 P6179 "1026949062" @default.
- Q46576489 P6216 Q50423863 @default.
- Q46576489 P8608 "release_hhm2qchpuzhppaqvv4iltvdhae" @default.
- Q46576489 P921 Q323936 @default.